Matches in SemOpenAlex for { <https://semopenalex.org/work/W2287443485> ?p ?o ?g. }
- W2287443485 endingPage "356" @default.
- W2287443485 startingPage "351" @default.
- W2287443485 abstract "Inhibition of phosphoinositide 3-kinase (PI3K) signaling is an appealing approach to treat brain tumors, especially glioblastoma multiforme (GBM). We previously disclosed our successful approach to prospectively design potent and blood-brain barrier (BBB) penetrating PI3K inhibitors. The previously disclosed molecules were ultimately deemed not suitable for clinical development due to projected poor metabolic stability in humans. We, therefore, extended our studies to identify a BBB penetrating inhibitor of PI3K that was also projected to be metabolically stable in human. These efforts required identification of a distinct scaffold for PI3K inhibitors relative to our previous efforts and ultimately resulted in the identification of GDC-0084 (16). The discovery and preclinical characterization of this molecule are described within." @default.
- W2287443485 created "2016-06-24" @default.
- W2287443485 creator A5005055708 @default.
- W2287443485 creator A5005497507 @default.
- W2287443485 creator A5008266584 @default.
- W2287443485 creator A5011579222 @default.
- W2287443485 creator A5013663538 @default.
- W2287443485 creator A5016302478 @default.
- W2287443485 creator A5017935216 @default.
- W2287443485 creator A5019802722 @default.
- W2287443485 creator A5028859676 @default.
- W2287443485 creator A5031820960 @default.
- W2287443485 creator A5038260469 @default.
- W2287443485 creator A5051871004 @default.
- W2287443485 creator A5053533157 @default.
- W2287443485 creator A5067239526 @default.
- W2287443485 creator A5068764000 @default.
- W2287443485 creator A5075146461 @default.
- W2287443485 creator A5075660811 @default.
- W2287443485 creator A5080833592 @default.
- W2287443485 creator A5090171528 @default.
- W2287443485 date "2016-02-17" @default.
- W2287443485 modified "2023-10-17" @default.
- W2287443485 title "Discovery of Clinical Development Candidate GDC-0084, a Brain Penetrant Inhibitor of PI3K and mTOR" @default.
- W2287443485 cites W2002424169 @default.
- W2287443485 cites W2008756733 @default.
- W2287443485 cites W2018671779 @default.
- W2287443485 cites W2025183726 @default.
- W2287443485 cites W2052245309 @default.
- W2287443485 cites W2088444678 @default.
- W2287443485 cites W2128527026 @default.
- W2287443485 cites W2169004576 @default.
- W2287443485 cites W2312511398 @default.
- W2287443485 cites W2356379002 @default.
- W2287443485 cites W781001238 @default.
- W2287443485 doi "https://doi.org/10.1021/acsmedchemlett.6b00005" @default.
- W2287443485 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4834666" @default.
- W2287443485 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27096040" @default.
- W2287443485 hasPublicationYear "2016" @default.
- W2287443485 type Work @default.
- W2287443485 sameAs 2287443485 @default.
- W2287443485 citedByCount "70" @default.
- W2287443485 countsByYear W22874434852016 @default.
- W2287443485 countsByYear W22874434852017 @default.
- W2287443485 countsByYear W22874434852018 @default.
- W2287443485 countsByYear W22874434852019 @default.
- W2287443485 countsByYear W22874434852020 @default.
- W2287443485 countsByYear W22874434852021 @default.
- W2287443485 countsByYear W22874434852022 @default.
- W2287443485 countsByYear W22874434852023 @default.
- W2287443485 crossrefType "journal-article" @default.
- W2287443485 hasAuthorship W2287443485A5005055708 @default.
- W2287443485 hasAuthorship W2287443485A5005497507 @default.
- W2287443485 hasAuthorship W2287443485A5008266584 @default.
- W2287443485 hasAuthorship W2287443485A5011579222 @default.
- W2287443485 hasAuthorship W2287443485A5013663538 @default.
- W2287443485 hasAuthorship W2287443485A5016302478 @default.
- W2287443485 hasAuthorship W2287443485A5017935216 @default.
- W2287443485 hasAuthorship W2287443485A5019802722 @default.
- W2287443485 hasAuthorship W2287443485A5028859676 @default.
- W2287443485 hasAuthorship W2287443485A5031820960 @default.
- W2287443485 hasAuthorship W2287443485A5038260469 @default.
- W2287443485 hasAuthorship W2287443485A5051871004 @default.
- W2287443485 hasAuthorship W2287443485A5053533157 @default.
- W2287443485 hasAuthorship W2287443485A5067239526 @default.
- W2287443485 hasAuthorship W2287443485A5068764000 @default.
- W2287443485 hasAuthorship W2287443485A5075146461 @default.
- W2287443485 hasAuthorship W2287443485A5075660811 @default.
- W2287443485 hasAuthorship W2287443485A5080833592 @default.
- W2287443485 hasAuthorship W2287443485A5090171528 @default.
- W2287443485 hasBestOaLocation W22874434851 @default.
- W2287443485 hasConcept C169760540 @default.
- W2287443485 hasConcept C178790620 @default.
- W2287443485 hasConcept C183713625 @default.
- W2287443485 hasConcept C185592680 @default.
- W2287443485 hasConcept C202751555 @default.
- W2287443485 hasConcept C2776194525 @default.
- W2287443485 hasConcept C2778402981 @default.
- W2287443485 hasConcept C2779335537 @default.
- W2287443485 hasConcept C2991874392 @default.
- W2287443485 hasConcept C502942594 @default.
- W2287443485 hasConcept C529278444 @default.
- W2287443485 hasConcept C55493867 @default.
- W2287443485 hasConcept C62478195 @default.
- W2287443485 hasConcept C70721500 @default.
- W2287443485 hasConcept C71924100 @default.
- W2287443485 hasConcept C86554907 @default.
- W2287443485 hasConcept C86803240 @default.
- W2287443485 hasConcept C95444343 @default.
- W2287443485 hasConcept C98274493 @default.
- W2287443485 hasConceptScore W2287443485C169760540 @default.
- W2287443485 hasConceptScore W2287443485C178790620 @default.
- W2287443485 hasConceptScore W2287443485C183713625 @default.
- W2287443485 hasConceptScore W2287443485C185592680 @default.
- W2287443485 hasConceptScore W2287443485C202751555 @default.
- W2287443485 hasConceptScore W2287443485C2776194525 @default.
- W2287443485 hasConceptScore W2287443485C2778402981 @default.
- W2287443485 hasConceptScore W2287443485C2779335537 @default.